Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.8606 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Suleima Arruda und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alopecia, Hair.
Abstract (Originalsprache)
BACKGROUND: REVIVV® is a topical hair growth serum with a proprietary formula of botanicals that addresses multiple factors involved in hair loss pathophysiology. This open-label, prospective, single-center study evaluated the efficacy of REVIVV®, a topical hair growth serum, in 20 adults (10 male, 10 female) with mild to moderate hair loss over 6 months. Participants applied the serum twice daily, and assessments were conducted at baseline, 4, 12, and 24 weeks. Dermatologist evaluations and patient self-assessments of hair quality and growth were performed using a 7-point Likert scale. Results Investigator-rated improvements in hair quality and growth increased from 0.75 and 0.81 at 4 weeks to 1.73 and 1.83 at 24 weeks, respectively. Patient-reported assessments showed that 85% of participants noted improved hair quality and growth at 24 weeks, with 50% reporting great improvement. Patient satisfaction was high, with 80% of participants being moderately or greatly satisfied at 4 weeks, increasing to 95% at 24 weeks. No adverse events related to the serum were reported throughout the study. The results demonstrate that twice-daily application of REVIVV® over 6 months is associated with increased hair growth and improved hair quality suggesting that REVIVV® may be an effective, non-pharmacological option for individuals seeking to improve hair growth and quality. J Drugs Dermatol. 2025;24(4):394-396. doi:10.36849/JDD.8606 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Arruda, S., Swearingen, A., Elmadany, Z., Nakagama, A., Lemoine, E. A., Valmeus, S. C., & Sadick, N. (2025). Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8606
Vancouver
Arruda S, Swearingen A, Elmadany Z, Nakagama A, Lemoine EA, Valmeus SC, et al. Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8606
BibTeX
@article{Arruda2025,
author = {Arruda, Suleima and Swearingen, Alyssa and Elmadany, Zahyaa and Nakagama, Anna and Lemoine, Emely Alvarado and Valmeus, Sophia Clara and Sadick, Neil},
title = {Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.8606}
}
EUVIMED